TCL Archive In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit December 18, 2009
TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009